Psychedelics

Wednesday Jan 06, 2021 - 2:08 pm

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) Releases Report on Patent Filings, Therapeutics Program Development

Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, has provided an update on its patent filings. The company has eight filings, all tied to Cybin’s novel therapeutics, delivery mechanisms and treatment regiments. The patent updates noted that Cybin has patent applications for the following: a provisional patent application for an oral film delivery mechanism covering all psychedelic molecules delivered through oral…

Wednesday Dec 30, 2020 - 10:35 am

InvestorNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) Commences Study to Further Knowledge in Psilocybin, Associated Delivery Mechanisms

Pure Extracts Technologies (CSE: PULL) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushrooms sector, today announced that it is commencing a study on the formulation and manufacturing of psilocybin-based active treatments for oral tablets, capsules and a nasal gel that will be used as an investigational product. According to the update, the study with be conducted at…

Wednesday Dec 30, 2020 - 10:25 am

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) Announces Q1 Results for Clarmin Explorations

Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, on Tuesday announced the unaudited financial results of Clarmin Explorations Inc. (now Cybin Inc.) for the three month period ended Oct. 31, 2020. According to the update, a copy of the consolidated financial statements prepared in accordance with International Financial Reporting Standards, as well as the corresponding management’s discussion and analysis for the…

Monday Dec 28, 2020 - 2:23 pm

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) on Track to Leverage Psychedelics to Target Depression

Cybin (NEO: CYBN), a mushroom life science company, is set to leverage opportunity amid growing research that demonstrates the significant role psilocybin could play in alleviating symptoms of major depression. According to a recent study conducted by Johns Hopkins Medicine and published in “JAMA Psychiatry,” only two doses of psilocybin accompanied with psychotherapy may lead to significant reductions in symptoms in adults with major depression…

Wednesday Dec 23, 2020 - 2:09 pm

InvestorNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Looks to Play ‘Pivotal Role’ in Supply Chain

Pure Extracts (CSE: PULL), a plant-based extraction company focused on cannabis, hemp and functional mushroom sectors, recently began trading on the Canadian Securities Exchange (“CSE”) under the symbol “PULL.” Pure Extracts leverages proprietary CO2 extraction methodology to obtain full-spectrum oil (“FSO”) from cannabis and hemp biomass. “We are pleased to have listed on the Canadian Securities Exchange as a significant first step towards Pure Extracts’…

Tuesday Dec 22, 2020 - 3:31 pm

InvestorNewsBreaks – Rritual Superfoods Inc. Eyes Growing Opportunity in Nascent Functional Mushrooms Market

Rritual, a plant-based consumer brand, is set to take advantage of opportunity as functional mushrooms move mainstream. Within the rapidly emerging functional foods industry, the functional mushrooms sector is projected to increase at a CAGR of 5.6% during 2021–2026 and reach $24.85 billion by the end of the forecast period. “Founded in 2019, Rritual has, to date, brought three mushroom-based products to market and is…

Wednesday Dec 16, 2020 - 11:04 am

InvestorNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Begins Facility Build-Out, Prepares to Apply for Dealer’s Licence

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company, has begun build-out work on the fourth unit in is extraction facility; in addition, the company is preparing to submit application to Health Canada requesting a dealer's licence under the Controlled Drugs and Substances Act (“CDSA”), the government entity that provides the framework for legal access to controlled substances, including the control and regulation of production,…

Tuesday Dec 15, 2020 - 10:48 am

InvestorNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Notes Appreciation for Health Canada Milestone Special Access Programme

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, has voiced its support and appreciation for Health Canada’s recently announced Special Access Programme (“SAP”) for psilocybin-assisted psychotherapy inclusion. The government entity recently announced its intent to revise the SAP and other related regulations to allow limited uses of psilocybin-assisted psychotherapeutic treatments. The SAP revision…

Monday Dec 14, 2020 - 10:57 am

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) Joins Forces with Adelia Therapeutics to Potentially Address Treatment Gaps Beyond Major Depressive Disorder

Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, today announced the close of its acquisition of 100% of the shares in Adelia Therapeutics Inc. for up to CA$20,161,575 (approximately US$15.75 million). “We are thrilled to join forces with Adelia. We see this acquisition as potentially advancing Cybin’s ability to innovate our psychedelic drug development program and diversify beyond major depressive disorder,”…

Thursday Dec 10, 2020 - 3:09 pm

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) Announces Agreement to Acquire Adelia Therapeutics

Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, recently announced its entry into a definitive agreement to acquire 100% of the shares in Adelia Therapeutics Inc. for up to CA$20,161,575 (approximately US$15.75 million) in an all-stock transaction. The transaction is subject to the satisfaction or waiver of customary conditions, including receipt of all applicable regulatory and NEO Exchange Inc. approvals. “We…

Thursday Dec 10, 2020 - 1:57 pm

InvestorNewsBreaks – Rritual Superfoods Inc. Holds Key Certification in Emerging Market

Rritual, a plant-based consumer brand, is a therapeutic foods innovator that is gaining attention as it helps build the emerging new market for healthful mushroom elixirs as a beneficial superfood. On the heels of its initial product launch and after snagging an ECRM Buyer’s Choice Award for its attractive marketing and growing market presence, Rritual has secured organic certification from the U.S. Department of Agriculture…

Thursday Dec 10, 2020 - 10:09 am

InvestorNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) Lays Groundwork for Move into World of Psychedelics

Pure Extracts Technologies (CSE: PULL) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, today announced its engagement of a globally recognized operations, compliance and regulatory consulting firm to advise on the company’s application to Health Canada for a Dealers Licence under the Controlled Drugs and Substances Act (“CDSA”). “Having the support of one of Canada’s premiere…

Wednesday Dec 09, 2020 - 10:02 am

InvestorNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Announces LOI with Owner of PURICA(TM) Brand of Wellness Product

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, recently signed a letter of intent with the Nutraceutical Medicine Company Inc. (“PURICA”). PURICA owns and distributes the PURICA product line of full-spectrum, mushroom-derived wellness products. Pure Extracts anticipates the PURICA brand will support PULL’s expansion into the functional mushroom sector. For the past two…

Wednesday Dec 02, 2020 - 10:22 am

InvestorNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Announces Working Collaboration with Leading Pharmaceutical Science Inventor

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company specializing in cannabis, hemp and mushroom products, has announced its partnership with Dr. Alexander MacGregor, a key scientific advisor the company. A renowned expert in pharmaceutical technology and novel drug-delivery systems, MacGregor is a dean of faculty and a distinguished professor of biopharmaceutics and current president of the Toronto Institute of Pharmaceutical Technology (“TIPT “), the premier…

Monday Nov 30, 2020 - 10:09 am

InvestorNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) Advances Move into Field of Mushroom Extractions

Pure Extracts Technologies (CSE: PULL) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sectors, on Thursday provided an update and overview regarding its expansion into the functional mushroom wellness sector. According to the update, interest is climbing sharply in functional and medicinal mushrooms, particularly regarding medicinal opportunities. Pure Extracts noted increased institutional interest in the field of…

Wednesday Nov 25, 2020 - 11:36 am

InvestorNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) Announces Executive Leadership Changes

Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) has announced that its executive leadership team will be changing; these changes follow last month’s naming of a new CEO and board chair along with a new vice chair. As a result of this week’s changes, the company is actively looking for new key executives, including a chief financial officer, chief general counsel and senior vice president…

Friday Nov 20, 2020 - 1:21 pm

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) Positioned as Early Entrant in Rapidly Growing Field of Psychedelics

UC Berkeley and other prominent academic institutions, including Johns Hopkins University in Maryland and Imperial College in London, are accelerating scientific research of psilocybin by launching a new center focusing on the compound (https://ibn.fm/VdvfN). Cybin (NEO: CYBN), a mushroom life science company, is positioned amid this growing research interest that is bringing psilocybin into mainstream. A recent article discussing the company reads, “Dedicated to supporting…

Thursday Nov 19, 2020 - 1:21 pm

InvestorNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) CEO Provides Corporate Update

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company specializing in cannabis, hemp and mushroom products, has released a corporate update from CEO and director Ben Nikolaevsky. The update includes information about the company’s new state-of-the-art facility, located in Pemberton, British Columbia, about 20 minutes north of Whistler, which was built to European Union GMP standards. The update also provides an overview of the company’s…

Wednesday Nov 18, 2020 - 2:59 pm

InvestorNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Leverages Distinctive 3-Pillar Strategy to Build Success

Pure Extracts (CSE: PULL), a plant-based extraction company focused on cannabis, hemp and functional mushroom sectors, recognizes the power of a carefully defined, strategic business model. Harvard Business Review touts this importance in an article titled “Why Business Models Matter.” The piece notes that good strategies are defined by answering age-old questions and gaining insight on the customer as well as the fundamentals and underlying…

Tuesday Nov 17, 2020 - 3:45 pm

InvestorNewsBreaks – Rritual Superfoods Inc. Delivers ‘Daily Dose’ Through Flagship Product Line

Rritual, a plant-based consumer brand, is a natural wellness innovator positioned at the heart of a fledgling industry rife with opportunity. According to Grand View Research Inc., the overall functional foods market is projected to reach $275.77 billion by 2025 (https://ibn.fm/5QUuu), and the demand for nutraceuticals and functional foods is now expected to surge even more than anticipated. Rritual has entered the market with its…

Friday Nov 13, 2020 - 1:32 pm

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) CEO Talks Company’s Psychedelic Research, Plans on Live Trading Show

Cybin (NEO: CYBN) CEO Doug Drysdale was featured on a recent episode of TraderTV Live. Broadcast live from the DTTW trading floor, TraderTV Live is the first and only professional trading show on YouTube Live. During the show, Drysdale discussed Cybin’s work on psychedelic medical research, including the company’s current phase 2 study. He also provided an overview of Cybin’s strategic plan moving forward in…

Thursday Nov 12, 2020 - 3:06 pm

InvestorNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Announces Board Appointment of Dwight Duncan

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp, and functional mushroom sectors, on Tuesday announced the appointment of Dwight Duncan to its board of directors. Duncan serves as a senior strategic advisor at McMillan LLP, a large Canadian full-service business law firm. He also serves as a principal of McMillan Vantage, McMillan LLP’s wholly owned public policy advisory firm, and…

Thursday Nov 12, 2020 - 12:43 pm

InvestorNewsBreaks – Rritual Receives USDA Organic Certification, Official Confirmation of Product Quality

Rritual announced that it has received the United States Department of Agriculture (“USDA”) Organic Certification. Awarded only after a demanding vetting process, the seal confirms the high quality of Rritual’s product lineup and manufacturing process. Rritual launched its original product lineup in September, which features products formulated with mindfully selected functional mushrooms and adaptogenic herbs. The products are designed to help relieve stress, improve cognitive function…

Wednesday Nov 11, 2020 - 10:21 am

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) Goes Public on Canada’s Next-Gen Stock Exchange

Cybin (NEO: CYBN), a leading Toronto-based biotech and life sciences company focused on psychedelic pharmaceutical therapies, today made its debut on the global public markets and is now trading on the NEO Exchange under the symbol “CYBN.” The company, which focuses on psychedelic drug development, unique delivery mechanisms, improved novel compounds and protocols, recently closed a C$45 million subscription receipt financing in relation to its…

Friday Nov 06, 2020 - 11:16 am

InvestorNewsBreaks – CYBIN Inc. Completes Reverse Takeover Transaction

CYBIN (formerly Clarmin Explorations Inc.), a life sciences company initially focused on psychedelic pharmaceutical therapies, on Thursday announced it has completed its previously disclosed reverse takeover of Clarmin Explorations Inc. per the terms of an amalgamation agreement dated June 26, 2020, as amended on October 21, 2020. The agreement was among Cybin Corp., Clarmin and 2762898 Ontario Inc. (“SubCo”), a wholly-owned subsidiary of the company…

Thursday Nov 05, 2020 - 10:24 am

InvestorNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Commences CSE Trading

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp, and functional mushroom sectors, today announced that, effective immediately, the company’s stock has commenced trading on the Canadian Securities Exchange (“CSE”) under the symbol “PULL.” “There currently is a tremendous consumer demand for natural health products with the ability to immediately enhance our quality of life. With Health Canada officially granting Pure…

Friday Oct 30, 2020 - 1:36 pm

InvestorNewsBreaks – Rritual Mushrooms Inc. Recognized at ECRM’s Whole Body & Mind Wellness Program

Rritual, a plant-based consumer wellness brand, was selected as runner up for the Buyers Choice Award at last week’s virtual ECRM program. According to an article on Business Wire, Rritual’s Reishi Relax Elixir was selected for the award among dozens of entries evaluated by retail buyers. “Retail buyers selected Rritual for the award because our packaging, design and formulation stood out amongst the dozens of…

Tuesday Oct 20, 2020 - 1:36 pm

InvestorNewsBreaks – Pure Extract Technologies Inc. Looks to Production of Highest-Quality FSO

Pure Extract, a private, plant-based extraction company, was recently awarded a Standard Processing License by Health Canada under the Cannabis Act. Following this significant milestone, Pure Extracts will now proceed with application to Health Canada for a Natural Health Products Site License at its purpose-built extraction facility while adhering to EU Good Manufacturing Practices (“GMP”). This will help to enable the company to extract its…

Tuesday Oct 20, 2020 - 1:10 pm

InvestorNewsBreaks – Why Rritual Mushrooms Inc. Is ‘One to Watch’

Rritual is a private company and premium brand in the emerging functional mushrooms market. The company is dedicated to helping people meet the demands of modern life with style and ease by enriching their diets through incorporating functional mushrooms, adaptogens and superfoods. Rritual manufactures premium plant-based products, with each featuring mindfully selected ingredients and designed to fit every lifestyle and meet the demands of customers…

InvestorNewsBreaks

NewsBreak Category: Psychedelics